These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
404 related articles for article (PubMed ID: 25409546)
1. Open-label, randomized, non-inferiority clinical trial of artesunate-amodiaquine versus artemether-lumefantrine fixed-dose combinations in children and adults with uncomplicated falciparum malaria in Côte d'Ivoire. Toure OA; Assi SB; N'Guessan TL; Adji GE; Ako AB; Brou MJ; Ehouman MF; Gnamien LA; Coulibaly MA; Coulibaly B; Beourou S; Bassinka I; Soumahoro A; Kadjo F; Tano MA Malar J; 2014 Nov; 13():439. PubMed ID: 25409546 [TBL] [Abstract][Full Text] [Related]
2. Multicentre study evaluating the non-inferiority of the new paediatric formulation of artesunate/amodiaquine versus artemether/lumefantrine for the management of uncomplicated Plasmodium falciparum malaria in children in Cameroon, Ivory Coast and Senegal. Faye B; Kuété T; Kiki-Barro CP; Tine RC; Nkoa T; Ndiaye JL; Kakpo CA; Sylla K; El Menan H; Gaye O; Faye O; Same-Ekobo A; Moussa K Malar J; 2012 Dec; 11():433. PubMed ID: 23270636 [TBL] [Abstract][Full Text] [Related]
3. Repeated treatment of recurrent uncomplicated Plasmodium falciparum malaria in Senegal with fixed-dose artesunate plus amodiaquine versus fixed-dose artemether plus lumefantrine: a randomized, open-label trial. Ndiaye JL; Faye B; Gueye A; Tine R; Ndiaye D; Tchania C; Ndiaye I; Barry A; Cissé B; Lameyre V; Gaye O Malar J; 2011 Aug; 10():237. PubMed ID: 21838909 [TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of artesuante-amodiaquine and artemether lumefantrine, the first line malaria treatment in six sentinel's sites of Côte d'Ivoire, West Africa. Toure OA; Assi SB; Kiki-Barro PMC; Yavo W; Abba T; Tiacoh LN; Konate AA; Angora EK; Bedia VA; Menan H; Daho AK; Emmanuel B Ann Parasitol; 2020; 66(4):561-571. PubMed ID: 33789028 [TBL] [Abstract][Full Text] [Related]
5. Efficacy of fixed-dose combination artesunate-amodiaquine versus artemether-lumefantrine for uncomplicated childhood Plasmodium falciparum malaria in Democratic Republic of Congo: a randomized non-inferiority trial. Espié E; Lima A; Atua B; Dhorda M; Flévaud L; Sompwe EM; Palma Urrutia PP; Guerin PJ Malar J; 2012 May; 11():174. PubMed ID: 22631564 [TBL] [Abstract][Full Text] [Related]
6. A comparative, randomized clinical trial of artemisinin/naphtoquine twice daily one day versus artemether/lumefantrine six doses regimen in children and adults with uncomplicated falciparum malaria in Côte d'Ivoire. Toure OA; Penali LK; Yapi JD; Ako BA; Toure W; Djerea K; Gomez GO; Makaila O Malar J; 2009 Jul; 8():148. PubMed ID: 19575797 [TBL] [Abstract][Full Text] [Related]
7. Pyronaridine-artesunate or dihydroartemisinin-piperaquine versus current first-line therapies for repeated treatment of uncomplicated malaria: a randomised, multicentre, open-label, longitudinal, controlled, phase 3b/4 trial. West African Network for Clinical Trials of Antimalarial Drugs (WANECAM) Lancet; 2018 Apr; 391(10128):1378-1390. PubMed ID: 29606364 [TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of a fixed-dose oral combination of pyronaridine-artesunate compared with artemether-lumefantrine in children and adults with uncomplicated Plasmodium falciparum malaria: a randomised non-inferiority trial. Tshefu AK; Gaye O; Kayentao K; Thompson R; Bhatt KM; Sesay SS; Bustos DG; Tjitra E; Bedu-Addo G; Borghini-Fuhrer I; Duparc S; Shin CS; Fleckenstein L; Lancet; 2010 Apr; 375(9724):1457-67. PubMed ID: 20417857 [TBL] [Abstract][Full Text] [Related]
9. Artesunate + amodiaquine versus artemether-lumefantrine for the treatment of uncomplicated Plasmodium falciparum malaria in the Colombian Pacific region: a noninferiority trial. De la Hoz Restrepo F; Porras Ramírez A; Rico Mendoza A; Córdoba F; Rojas DP Rev Soc Bras Med Trop; 2012 Dec; 45(6):732-8. PubMed ID: 23295878 [TBL] [Abstract][Full Text] [Related]
10. Randomized, multicentre assessment of the efficacy and safety of ASAQ--a fixed-dose artesunate-amodiaquine combination therapy in the treatment of uncomplicated Plasmodium falciparum malaria. Ndiaye JL; Randrianarivelojosia M; Sagara I; Brasseur P; Ndiaye I; Faye B; Randrianasolo L; Ratsimbasoa A; Forlemu D; Moor VA; Traore A; Dicko Y; Dara N; Lameyre V; Diallo M; Djimde A; Same-Ekobo A; Gaye O Malar J; 2009 Jun; 8():125. PubMed ID: 19505304 [TBL] [Abstract][Full Text] [Related]
11. In vivo efficacy of artesunate-amodiaquine and artemether-lumefantrine for the treatment of uncomplicated falciparum malaria: an open-randomized, non-inferiority clinical trial in South Kivu, Democratic Republic of Congo. de Wit M; Funk AL; Moussally K; Nkuba DA; Siddiqui R; Bil K; Piriou E; Bart A; Bahizi Bizoza P; Bousema T Malar J; 2016 Sep; 15(1):455. PubMed ID: 27599612 [TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of artemether + lumefantrine, artesunate + sulphamethoxypyrazine-pyrimethamine and artesunate + amodiaquine and sulphadoxine-pyrimethamine + amodiaquine in the treatment of uncomplicated falciparum malaria in Bangui, Central African Republic: a randomized trial. Djallé D; Njuimo SP; Manirakiza A; Laganier R; Le Faou A; Rogier C Malar J; 2014 Jan; 13():9. PubMed ID: 24393479 [TBL] [Abstract][Full Text] [Related]
13. Multicentric assessment of the efficacy and tolerability of dihydroartemisinin-piperaquine compared to artemether-lumefantrine in the treatment of uncomplicated Plasmodium falciparum malaria in sub-Saharan Africa. Yavo W; Faye B; Kuete T; Djohan V; Oga SA; Kassi RR; Diatta M; Ama MV; Tine R; Ndiaye JL; Evi JB; Same-Ekobo A; Faye O; Koné M Malar J; 2011 Jul; 10():198. PubMed ID: 21774826 [TBL] [Abstract][Full Text] [Related]
14. Efficacy and tolerability of artesunate-amodiaquine (Camoquin plus) versus artemether-lumefantrine (Coartem) against uncomplicated Plasmodium falciparum malaria: multisite trial in Senegal and Ivory Coast. Faye B; Offianan AT; Ndiaye JL; Tine RC; Touré W; Djoman K; Sylla K; Ndiaye PS; Penali L; Gaye O Trop Med Int Health; 2010 May; 15(5):608-13. PubMed ID: 20214761 [TBL] [Abstract][Full Text] [Related]
15. Efficacy and tolerability of artesunate-amodiaquine versus artemether-lumefantrine in the treatment of uncomplicated Plasmodium falciparum malaria at two sentinel sites across Côte d’Ivore. Konaté A; Barro-Kiki PCM; Angora KE; Bédia-Tanoh AV; Djohan V; Kassi KF; Vanga-Bosson H; Miézan AJS; Assi SB; Menan EIH; Yavo W Ann Parasitol; 2018; 64(1):49–57. PubMed ID: 29717574 [TBL] [Abstract][Full Text] [Related]
16. Artesunate-amodiaquine versus artemether-lumefantrine for the treatment of acute uncomplicated malaria in Congolese children under 10 years old living in a suburban area: a randomized study. Ndounga M; Pembe Issamou Mayengue ; Casimiro PN; Koukouikila-Koussounda F; Bitemo M; Diassivy Matondo B; Ndounga Diakou LA; Basco LK; Ntoumi F Malar J; 2015 Oct; 14():423. PubMed ID: 26511848 [TBL] [Abstract][Full Text] [Related]
17. In vivo efficacy of artemether-lumefantrine and artesunate-amodiaquine for uncomplicated Plasmodium falciparum malaria in Malawi, 2014. Paczkowski M; Mwandama D; Marthey D; Luka M; Makuta G; Sande J; Ali D; Troell P; Mathanga DP; Gutman J Malar J; 2016 Apr; 15():236. PubMed ID: 27113085 [TBL] [Abstract][Full Text] [Related]
18. An open label, randomised trial of artesunate+amodiaquine, artesunate+chlorproguanil-dapsone and artemether-lumefantrine for the treatment of uncomplicated malaria. Owusu-Agyei S; Asante KP; Owusu R; Adjuik M; Amenga-Etego S; Dosoo DK; Gyapong J; Greenwood B; Chandramohan D PLoS One; 2008 Jun; 3(6):e2530. PubMed ID: 18575626 [TBL] [Abstract][Full Text] [Related]
19. Artemether-lumefantrine versus artesunate plus amodiaquine for treating uncomplicated childhood malaria in Nigeria: randomized controlled trial. Meremikwu M; Alaribe A; Ejemot R; Oyo-Ita A; Ekenjoku J; Nwachukwu C; Ordu D; Ezedinachi E Malar J; 2006 May; 5():43. PubMed ID: 16704735 [TBL] [Abstract][Full Text] [Related]
20. Safety of a fixed-dose combination of artesunate and amodiaquine for the treatment of uncomplicated Plasmodium falciparum malaria in real-life conditions of use in Côte d'Ivoire. Assi SB; Aba YT; Yavo JC; Nguessan AF; Tchiekoi NB; San KM; Bissagnéné E; Duparc S; Lameyre V; Tanoh MA Malar J; 2017 Jan; 16(1):8. PubMed ID: 28049523 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]